Saamya Biotech Limited Announces Audited Earnings Results for the Fourth Quarter and Year Ended March 31, 2013
For the year, the company reported net loss of INR 3,999,351 or INR 0.16 basic and diluted loss per share after extra ordinary items on net sales/income from operations of compared to net profit of INR 2,786,789 or INR 0.11 basic and diluted earnings per share after extra ordinary items on net sales/income from operations of for the corresponding period last year. Loss from ordinary activities before tax was INR 4,064,506 against profit from ordinary activities before tax of INR 3,540,212 for the same period last year. Loss from operations before other income, interest & exceptional items was INR 3,881,166 against INR 2,888,035 of prior year period.